Panagora Asset Management Inc Soligenix, Inc. Transaction History

Panagora Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$0.88 - $1.04 $30,114 - $35,589	-34,221 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$0.85 - $2.1 $29,087 - $71,864	34,221 New	34,221 $29,000
Q3 2018 Nov 13, 2018	SELL	$0.98 - $1.97 $141 - $283	-144 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$0.92 - $1.91 $16,018 - $33,255	-17,411 Reduced 99.18%	144 $0
Q1 2018 May 15, 2018	SELL	$1.92 - $2.4 $31,178 - $38,973	-16,239 Reduced 48.05%	17,555 $34,000
Q4 2017 Feb 14, 2018	BUY	$1.84 - $2.32 $4,327 - $5,456	2,352 Added 7.48%	33,794 $75,000
Q3 2017 Nov 14, 2017	BUY	$2.01 - $2.27 $63,198 - $71,373	31,442	31,442 $70,000

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $119M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.